Johnson & Johnson (JNJ) financial statements

+54.2%since 2007
FY2025 revenue
$94.2B▲ +6.0%
FY2025 net income
$26.8B▲ +90.6%
FY2025 diluted EPS
$11.03▲ +90.5%
FY2025 free cash flow
$19.7B▼ −0.7%

Johnson & Johnson income statement

Johnson & Johnson income statement
USD millionsFY2025FY2024FY2023
Period ended28 Dec 202529 Dec 202431 Dec 2023
Revenue94,19388,82185,159
Gross profit63,93761,35058,606
Pretax income32,58116,68715,062
Net income26,80414,06635,153
Diluted earnings per share11.035.7913.72

Johnson & Johnson balance sheet

Johnson & Johnson balance sheet
USD millionsFY2025FY2024FY2023
Period ended28 Dec 202529 Dec 202431 Dec 2023
Cash and cash equivalents19,70924,10521,859
Total assets199,210180,104167,558
Total liabilities117,666108,61498,784
Total equity81,54471,49068,774
Long-term debt39,43830,65125,881

Johnson & Johnson cash flow statement

Johnson & Johnson cash flow statement
USD millionsFY2025FY2024FY2023
Period ended28 Dec 202529 Dec 202431 Dec 2023
Operating cash flow24,53024,26622,791
Capital expenditure-4,832-4,424-4,543
Free cash flow (derived)19,69819,84218,248
Share repurchases-5,953-2,432-5,054

Quarterly highlights

Quarterly highlights
USD millionsQ3 FY2026Q2 FY2026Q1 FY2026Q4 FY2025
Period ended27 Sep 202628 Jun 202629 Mar 202628 Dec 2025
Revenue (derived)25,39925,31024,06224,564
Net income (derived)2105,5345,2355,116
Diluted earnings per share0.092.272.14n/a
Operating cash flow (derived)7,7208,6162,5147,309
Total assets197,425201,061200,894199,210

Johnson & Johnson major shareholders

Johnson & Johnson major shareholders
HolderShare of classSharesFiled
Vanguard Capital Management7.5%180,631,2281 May 2026

Johnson & Johnson 10-K and SEC filings

Johnson & Johnson 10-K and SEC filings
FiledFormTypeDescription
21 October 202610-QQuarterly reportQuarterly report
13 October 20268-KCurrent reportCurrent report
4 August 20268-KCurrent reportCurrent report
29 July 20268-KCurrent reportCurrent report
28 July 20268-KCurrent reportCurrent report
23 July 202610-QQuarterly reportQuarterly report
15 July 20268-KCurrent reportCurrent report
27 April 20268-KCurrent reportCurrent report

Common questions

What was Johnson & Johnson's revenue in fiscal 2025?

Johnson & Johnson reported $94.2 billion in revenue for fiscal 2025, the year ended 28 December 2025, up 6.0% from fiscal 2024.

What was Johnson & Johnson's net income in fiscal 2025?

Johnson & Johnson reported net income of $26.8 billion for fiscal 2025, the year ended 28 December 2025, up 90.6% from fiscal 2024. Diluted earnings per share were $11.03.

What was Johnson & Johnson's free cash flow in fiscal 2025?

Johnson & Johnson had $19.7 billion in free cash flow in fiscal 2025. Operating cash flow was $24.5 billion and capital expenditure was $4.8 billion.

What were Johnson & Johnson's total assets at the end of fiscal 2025?

Johnson & Johnson reported total assets of $199.2 billion at the end of fiscal 2025, the year ended 28 December 2025.

How much Johnson & Johnson history do I get?

Every account gets the full history, annual and quarterly, with first reported values and as of dates.